| Original language | English |
|---|---|
| Pages (from-to) | 11809-11811 |
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Volume | 114 |
| Issue number | 45 |
| DOIs |
|
| Publication status | Published - 7 Nov 2017 |
| Externally published | Yes |
Funding
The authors’ research is supported by National Institutes of Health (NIH) Grant GM108617 and by University of Iowa Holden Comprehensive Cancer Center Collaborative Pilot Grant NIH P30 CA086862 (to M.S.). C.C.C. is supported by NIH T32 Pharmacological Sciences Training Grant GM067795. C.C.C. is supported by NIH T32 Pharmacological Sciences Training Grant GM067795.
| Funders | Funder number |
|---|---|
| C.C.C. | |
| NIH T32 Pharmacological Sciences Training | GM067795 |
| National Institutes of Health | |
| National Institute of General Medical Sciences | R01GM108617 |
| Holden Comprehensive Cancer Center, University of Iowa | NIH P30 CA086862 |
| M.S.I. Foundation |